Balance Sheet
Cash Flow Statement
Beginning Cash BalanceGains from Sales and Divestitures
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Change in Inventory: 2017-2022

Historic Change in Inventory for RedHill Biopharma (RDHL) over the last 5 years, with Dec 2022 value amounting to $1.6 million.

  • RedHill Biopharma's Change in Inventory rose 192.87% to $1.6 million in Q4 2022 from the same period last year, while for Dec 2022 it was $3.8 million, marking a year-over-year increase of 145.88%. This contributed to the annual value of $738,000 for FY2024, which is 69.08% down from last year.
  • Latest data reveals that RedHill Biopharma reported Change in Inventory of $1.6 million as of Q4 2022, which was up 282.08% from -$865,000 recorded in Q3 2022.
  • RedHill Biopharma's Change in Inventory's 5-year high stood at $2.6 million during Q2 2022, with a 5-year trough of -$4.4 million in Q3 2021.
  • Over the past 3 years, RedHill Biopharma's median Change in Inventory value was -$875,000 (recorded in 2020), while the average stood at -$760,667.
  • As far as peak fluctuations go, RedHill Biopharma's Change in Inventory slumped by 1,905.06% in 2020, and later skyrocketed by 403.55% in 2022.
  • RedHill Biopharma's Change in Inventory (Quarterly) stood at -$300,000 in 2018, then skyrocketed by 126.33% to $79,000 in 2019, then tumbled by 1,905.06% to -$1.4 million in 2020, then fell by 18.93% to -$1.7 million in 2021, then skyrocketed by 192.87% to $1.6 million in 2022.
  • Its Change in Inventory stands at $1.6 million for Q4 2022, versus -$865,000 for Q3 2022 and $2.6 million for Q2 2022.